Form 8-K - Current report:
SEC Accession No. 0001144204-11-035916
Filing Date
2011-06-15
Accepted
2011-06-15 16:01:22
Documents
2
Period of Report
2011-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v225929_8k.htm 8-K 26506
2 v225929_ex99-1.htm EX-99.1 13159
  Complete submission text file 0001144204-11-035916.txt   40993
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 11913051
SIC: 2836 Biological Products, (No Diagnostic Substances)